Executive interview – Kane Biotech

Executive interview – Kane Biotech

Kane Biotech (TSX-V: KNE, OTCQB: KNBIF) is taking a unique approach to addressing human and animal health by developing technology to break up biofilms, the glue-like substance secreted by microorganisms that prevent their removal. Biofilms are implicated in a range of health concerns from periodontal disease, medical device-associated infections, hospital-acquired infections and food safety.


You may also be interested in these:

Healthcare

SynAct Pharma – executive interview

TMT

IP Group – executive interview